Name: UMIN ID:
Unique ID issued by UMIN | UMIN000023591 |
---|---|
Receipt number | R000027167 |
Scientific Title | Feasibility study of neoadjuvant gemcitabine plus nab-paclitaxel for borderline resectable pancreatic cancer |
Date of disclosure of the study information | 2016/08/10 |
Last modified on | 2019/03/07 16:21:25 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/08/10 20:43:26 | ||
2 | Update | 2018/01/12 08:57:29 | ||
3 | Update | 2018/09/20 10:37:27 | Recruitment status |
|
4 | Update | 2019/01/31 18:53:33 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
5 | Update | 2019/03/07 16:21:25 | Recruitment status |